Skip to main content

Many people worldwide become overweight and even extremely overweight, which forces the need for new types of anti-obesity medications that effectively can at least control the body processes that lead to these conditions. There is a largely spread misconception that people have the willpower to cope with this specific condition. In other words, it’s thought that if a person tries to control the hunger, and the cravings every minute, they will lose weight, but it’s not the way it works in practice. That’s mainly because the cause of obesity is deeply rooted in psychological factors. The condition is a complex metabolic disease and helping the patients needs to be on different levels.

Different Types of Medications for Weight Loss

The different types of weight loss medications work in various ways and their effectiveness depends on the specific metabolic and body characteristics. One of the most popular in the last few years is The GLP-1 receptor agonists. They work by mimicking a hormone called glucagon-like peptide-1 (GLP-1), which releases insulin after you eat and sends a signal to the brain that you are full. This newest class of weight loss drugs also slows down the action of the gut, to keep you feeling fuller for longer.

• Danish Novo Nordisk’s Ozempic and Wegovy with the active substance semaglutide, a once-weekly injection, which are approved to treat type-2 diabetes, but not weight loss. Although they consist of the same active ingredient, these medicines are not completely interchangeable. People using them achieved good progress, that is why the drugs are quite usable off-label. It means it’s used for a purpose other than those it is approved to treat.
Zepbound (weight loss) and Mounjaro (diabetes) with active substance tripeptide, a once-weekly injection, manufactured by the US company Eli Lilly
Saxenda and Victoza with active substance liraglutide, a daily injection, which can be used also by children above 10 years old, again manufactured by the Danish company Novo Nordisk

Stimulants (Prescription Medications Obesity)

Another type of weight loss medicine is Stimulants, which have a long history in obesity treatment. An example is Qsymia. This medication contains two active ingredients: phentermine, a medication similar to amphetamines, and topiramate, an anti-seizure medication. Together, they reduce appetite and can lead to weight loss. Phentermine has been used for decades and is the most widely prescribed weight loss treatment.

Combination pills

The third drug class is Opioid antagonist combination pills. Contrave and Mysimba are such weight loss pills that have two active ingredients: naltrexone, an opioid antagonist, which is used to treat substance use disorder, and bupropion, an antidepressant that also helps people stop smoking. The combination of the two can decrease cravings and keep people feeling full for longer.

Diet Pills

The fourth type of prescription medication to try to aid obesity is diet pills. Some diet pills work by limiting the amount of fat that your body can absorb or how it forms fat deposits. Within this category, there are two types of weight loss pills, including an over-the-counter option, which are:

• Lipase inhibitors slow down the absorption of fat in the gut. Together with a low-fat diet, they can facilitate weight loss. A representative of this group is Alli an over-the-counter pill and Xenical (orlistat) is a prescription lipase inhibitor.
• Imcivree (setmelanotide) is a melanocortin receptor agonist that’s used for the treatment of genetic obesity caused by a rare single-gene mutation

One of these medicines can be prescribed for overweight, but the question of safety and side effects remains. All of them have different side effects, which should be carefully reconsidered according to the individual’s health status.

On the opposite side to help with the kilograms some natural food supplements can be used based on hesperidin. It’s a flavanone glycoside – a natural phenolic compound with a wide range of biological effects. Mounting evidence has demonstrated that hesperidin possesses an inhibitory effect against obesity diseases. Hesperidin actually regulates lipid metabolism and glucose metabolism, directly regulates antioxidant index and anti-apoptosis, and indirectly regulates inflammation to play a role in the treatment of obesity. The newest researches show how big the potential of this product is against the over weight globally. 

We, at MVS Pharma strive to aid people in their health and wellness journey by creating and providing all-natural, high-quality products. There is a way not to use prescription medications to treat obesity and we are going to share it with our future clients.  We conduct our own research on how to aid obesity and are on the path of creating an all-natural supplement, called LipoShin to do just that! You can read all about it on its official product page.

Disclaimer:

As a service to our readers, MVS Pharma GmbH publishing provides access to our library of archived content — in our blogPlease note the date of the last review or update on all articles. No content on this site should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.

MVS Pharma GmbH will soon be launching an omega-3 dietary supplement onto the European market that has been developed for the highest quality standards in terms of oxidation avoidance and therefore greatest bioavailability. In addition, in vitro studies are currently underway at the University of Ulm, in which Professor Dr. Rüdiger Groß tested a patented mouth and nose spray (Virudol) that can eliminate various flu viruses based on natural substances. In addition, MVS has a wholesale license and has specialized in sourcing much-needed medicines such as Amoxicillin, Salbutamol, etc. from India through its local branch with a focus on local quality and safety testing, compliance with international GMP regulations and the highest quality level of user security (examples of local language brochures, identical units of measurement, batch control and full tracking, etc.)

Managing Director of MVS Pharma Bulgaria Ltd Miglena Racheva

Miglena is the Managing Director of MVS Pharma Bulgaria Ltd. She is in charge of our Administration Company in Bulgaria – MVS Pharma Bulgaria Ltd. She makes sure that all the documentation complies with EU’s regulations, executes deep dive researches on various projects and topics, and oversees every plan and action of the company.